Nanobiotix (NBTX) Receivables (2019 - 2025)

Historic Receivables for Nanobiotix (NBTX) over the last 6 years, with Q2 2025 value amounting to $2.1 million.

  • Nanobiotix's Receivables fell 3813.06% to $2.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.1 million, marking a year-over-year decrease of 3813.06%. This contributed to the annual value of $6.4 million for FY2024, which is 15632.43% up from last year.
  • According to the latest figures from Q2 2025, Nanobiotix's Receivables is $2.1 million, which was down 3813.06% from $6.4 million recorded in Q4 2024.
  • Nanobiotix's Receivables' 5-year high stood at $6.4 million during Q4 2024, with a 5-year trough of $253959.5 in Q2 2022.
  • Over the past 4 years, Nanobiotix's median Receivables value was $2.5 million (recorded in 2023), while the average stood at $2.7 million.
  • In the last 5 years, Nanobiotix's Receivables surged by 36736.89% in 2023 and then tumbled by 3813.06% in 2025.
  • Quarter analysis of 4 years shows Nanobiotix's Receivables stood at $2.9 million in 2022, then dropped by 13.8% to $2.5 million in 2023, then soared by 154.43% to $6.4 million in 2024, then crashed by 67.3% to $2.1 million in 2025.
  • Its Receivables stands at $2.1 million for Q2 2025, versus $6.4 million for Q4 2024 and $3.4 million for Q2 2024.